US Broker Ratings

TG Therapeutics, Inc. (TGTX) Stock Analysis: A Biotech Powerhouse with 26% Upside Potential

TG Therapeutics, Inc. (NASDAQ: TGTX) stands as a formidable player in the biotechnology sector, with a compelling narrative that has captured the attention of investors. With a market capitalization of..

Alnylam Pharmaceuticals, Inc. (ALNY) Stock Analysis: A High-Valuation Biotech with Strong Analyst Confidence

Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY), a leader in RNA interference (RNAi) therapeutics, stands out in the biotechnology sector with a significant market capitalization of $59.45 billion. Based in Cambridge, Massachusetts,..

iRhythm Technologies, Inc. (IRTC) Stock Analysis: Navigating the Potential Upside in a Volatile Market

Investors have their eyes on iRhythm Technologies, Inc. (NASDAQ: IRTC), a standout player in the healthcare sector, particularly in the medical devices industry. Known for its pioneering work in ambulatory..

Axsome Therapeutics, Inc. (AXSM) Stock Analysis: Exploring a Potential 52.51% Upside in the CNS Therapeutics Market

Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company specializing in treatments for central nervous system (CNS) disorders, is making waves in the biotechnology sector with its promising pipeline and robust..

AstraZeneca PLC (AZN): Investor Outlook with a 14.54% Potential Upside and Strong Buy Ratings

AstraZeneca PLC (AZN) stands prominently as a global leader in the healthcare sector, with a particular focus on the discovery, development, and commercialization of prescription medicines. With a market capitalization..

DexCom, Inc. (DXCM) Stock Analysis: A 51% Upside Potential and Strong Buy Consensus

For investors seeking promising opportunities in the healthcare sector, DexCom, Inc. (NASDAQ: DXCM) presents a compelling case. As a leading player in the medical devices industry, DexCom specializes in continuous..

Insulet Corporation (PODD) Stock Analysis: A 32.9% Revenue Growth Powerhouse with Robust Buy Ratings

Insulet Corporation (NASDAQ: PODD) continues to make waves in the healthcare sector, specifically within the medical devices industry, with its innovative insulin delivery systems. The company, headquartered in Acton, Massachusetts,..

Telix Pharmaceuticals Limited (TLX) Stock Analysis: A Biotech Star with 120% Potential Upside

Telix Pharmaceuticals Limited (ASX: TLX), a burgeoning Australian biotechnology company, is increasingly capturing the attention of investors with its impressive growth trajectory and promising product pipeline. Specializing in the development..

Elanco Animal Health (ELAN) Stock Analysis: Navigating Growth Amidst Mixed Ratings

Elanco Animal Health Incorporated (NYSE: ELAN), a prominent player in the healthcare sector, continues to assert its influence in the drug manufacturing industry, specializing in both specialty and generic products..

Teleflex Incorporated (TFX) Stock Analysis: Navigating Healthcare Potential with an 8.15% Upside

Teleflex Incorporated (NYSE: TFX) stands as a significant player in the healthcare sector, specializing in the design and production of single-use medical devices essential for critical care and surgical applications...

Chemed Corp (CHE) Stock Analysis: Exploring a Potential Upside of Nearly 28%

Chemed Corp (NYSE: CHE), a prominent player in the healthcare sector, specifically within the medical care facilities industry, commands investor attention with its diverse service offerings and promising financial outlook...

Edwards Lifesciences Corporation (EW) Stock Analysis: A 17.45% Upside Potential with Robust Growth Prospects

Edwards Lifesciences Corporation (EW), a leading player in the healthcare sector, specifically within the medical devices industry, presents a compelling investment opportunity for those looking to capitalize on its innovative..

Rhythm Pharmaceuticals (RYTM) Stock Analysis: Exploring a 17% Upside in the Biotech Sector

Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM), a commercial-stage biopharmaceutical company, is gaining significant attention from investors with its focus on rare neuroendocrine diseases and a promising potential upside of 17.11%. The..

Inspire Medical Systems, Inc. (INSP) Stock Analysis: Exploring an 80.94% Potential Upside in the Healthcare Sector

Inspire Medical Systems, Inc. (NASDAQ: INSP) is a standout player in the medical devices industry, focusing on innovative solutions for obstructive sleep apnea (OSA). With a market capitalization of $2.36..

ADMA Biologics Inc (ADMA) Stock Analysis: 82.65% Potential Upside Ignites Investor Interest

ADMA Biologics Inc (ADMA), a key player in the biotechnology sector, is capturing significant attention from investors, fueled by a notable potential upside of 82.65%. As a company dedicated to..

Cardinal Health, Inc. (CAH) Stock Analysis: Evaluating a 20.85% Potential Upside in the Healthcare Sector

Cardinal Health, Inc. (NYSE: CAH), a key player in the healthcare sector, offers a compelling opportunity for investors, with analysts predicting a potential upside of 20.85%. With a substantial market..

Sarepta Therapeutics, Inc. (SRPT) Stock Analysis: Exploring a 37.46% Potential Upside Amidst a Tumultuous Market

Sarepta Therapeutics, Inc. (NASDAQ: SRPT) stands as a beacon of innovation in the biotechnology sector, with its focus on RNA-targeted therapeutics and gene therapies for rare diseases. As a commercial-stage..

Boston Scientific Corporation (BSX) Stock Analysis: Promising 27% Upside Potential Amid Robust Growth

Boston Scientific Corporation (NYSE: BSX), a prominent player in the healthcare sector, particularly within the medical devices industry, is capturing investor attention with a market capitalization of $144.96 billion and..

Dr. Reddy’s Laboratories Ltd (RDY) Stock Analysis: Navigating a Potential 1.98% Upside in the Pharmaceutical Space

Dr. Reddy’s Laboratories Ltd (RDY) stands as a formidable player in the global pharmaceutical industry, with a notable presence in North America, Europe, India, and Russia. With a market capitalization..

Encompass Health Corporation (EHC): Investor Outlook on a Healthcare Leader with a 10.77% Upside Potential

For those keen on the healthcare sector, Encompass Health Corporation (NYSE: EHC) presents a compelling investment opportunity. With a market capitalization of $12.5 billion, this Birmingham, Alabama-based giant stands as..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds